Peptide-based immunotherapy in lupus: Where are we now?

By sjmartinez • October 2, 2023

P Singh R, S Bischoff D, S Singh S, H Hahn B. Peptide-based immunotherapy in lupus: Where are we now? Rheumatol Immunol Res. 2023 Sep 27;4(3):139-149. doi: 10.2478/rir-2023-0020. PMID: 37781681; PMCID: PMC10538607.

Tags: chemokine, cytokine, Geriatrics, immune tolerance, immunotherapy, lupus, peptide, Publications, regulatory T cells, Rheumatology, Veterans Administration

Incorporating staffing instability in the nursing home Five-Star Staffing Composite

Mukamel DB, Saliba D, Ladd H, Konetzka RT. Incorporating staffing instability in the nursing home Five-Star Staffing Composite. Health Aff Sch. 2024 Dec 16;2(12):qxae159. doi:[...]

Increased mitochondrial mutation heteroplasmy induces aging phenotypes in pluripotent stem cells and their differentiated progeny

Vandiver AR, Torres A Jr, Sanden A, Nguyen TL, Gasilla J, Doan MT, Martirosian V, Hoang A, Wanagat J, Teitell MA. Increased mitochondrial mutation heteroplasmy[...]

Post-Acute Care Admissions Among Medicare Beneficiaries with Disabilities During Payment Reform and the COVID-19 Pandemic

Prusynski R, Leland NE, Humbert A, Amaravadi H, Brown C, Dahal A, Saliba D, Mroz TM. Post-Acute Care Admissions Among Medicare Beneficiaries with Disabilities During[...]